Report map of MCI diagnostics and management

Deliverable 1.1 is a report mapping the mild cognitive impairment (MCI) diagnostics and management in the European countries participating in the project’s clinical study: Finland, Italy, Norway, and Spain.

The purpose of this report is to identify the state-of-the-art tools and depict the current clinical practices used for the diagnosis and management of MCI in the four AI-Mind European countries participating in the project’s clinical study.

Through a 22-question online survey (Annex I), we collected information on the diagnostics, treatment, and management of MCI, as well as on the clinicians’ acceptance and reliance on AI-based diagnostic tools. We analysed the collected data based on scientific literature and guidelines on how MCI is diagnosed, treated, and managed. Additionally, we mapped the healthcare professionals' expectations towards the clinical use of a potential digital AI-based tool for dementia risk-estimation, including issues like their view on reliability, trust, and anticipated patients' acceptance of such technology.